JNK inhibitors specifically target c-Jun N-terminal kinases, a subgroup of MAP kinases involved in stress responses, apoptosis, and inflammation. These reagents are used to investigate JNK-mediated pathways in cellular models of neurodegeneration, ischemia, and immune responses.